The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...
The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results